2-(4-((2-Oxocyclopentyl)methyl)phenyl)propanoic acid, 95.0%, 25g

7-Aminocephalosporanic acid, 95.0%, 10g

3-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

9,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene>98.0%(GC)5g

4-Bromo-7-(trifluoromethyl)quinoline, 95.0%, 5g

GC capillary column ROTI®Cap-1, 30 m, 0.25 mm, 0.10 µm, 1 Piece(s)

5-Fluoro-3-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indole, 1g

Tetramisole Hydrochloride>98.0%(HPLC)(N)10g

Ezetimibe>95.0%(T)5g

N-(4-Chloro-3-methoxyphenyl)acetamide, 95.0%, 1g

3,3-Diethoxybutan-2-one, 95%, 100mg

GC capillary column ROTI®Cap-5 MS, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

N-(furan-2-ylmethyl)-1-phenylpropan-2-amine, 98%, 250mg